about
Transthyretin and the brain re-visited: is neuronal synthesis of transthyretin protective in Alzheimer's disease?Mechanism of Action and Clinical Application of Tafamidis in Hereditary Transthyretin AmyloidosisUnderstanding How the Subcommissural Organ and Other Periventricular Secretory Structures Contribute via the Cerebrospinal Fluid to NeurogenesisPlasma Transthyretin as a Biomarker of Lean Body Mass and Catabolic StatesVKORC1 pharmacogenetics and pharmacoproteomics in patients on warfarin anticoagulant therapy: transthyretin precursor as a potential biomarkerIdentification and validation of novel cerebrospinal fluid biomarkers for staging early Alzheimer's diseaseTransthyretin Cardiac Amyloidosis in Older Americans.Physiological IgM class catalytic antibodies selective for transthyretin amyloid.Gene signatures in wound tissue as evidenced by molecular profiling in the chick embryo model.Transthyretin as a potential biomarker for the differential diagnosis between lung cancer and lung infection.The relative amounts of plasma transthyretin forms in familial transthyretin amyloidosis: a quantitative analysis by Fourier transform ion-cyclotron resonance mass spectrometry.Multi-peptide nLC-PC-IDMS-SRM-based assay for the quantification of biomarkers in the chicken ovarian cancer modelProteomic evaluation of sheep serum proteins.Quantification of quaternary structure stability in aggregation-prone proteins under physiological conditions: the transthyretin case.Sulfated glycosaminoglycans accelerate transthyretin amyloidogenesis by quaternary structural conversionHeparan sulfate/heparin promotes transthyretin fibrillization through selective binding to a basic motif in the protein.Amyloidogenic and non-amyloidogenic transthyretin variants interact differently with human cardiomyocytes: insights into early events of non-fibrillar tissue damage.Cooperative stabilization of transthyretin by clusterin and diflunisal.Modulating inhibitors of transthyretin fibrillogenesis via sulfation: polychlorinated biphenyl sulfates as models.Mechanisms of transthyretin cardiomyocyte toxicity inhibition by resveratrol analogs.Neuronal production of transthyretin in human and murine Alzheimer's disease: is it protective?Protein profiling of isolated uterine AA amyloidosis causing fetal death in goats.Signaling by vitamin A and retinol-binding protein in regulation of insulin responses and lipid homeostasis.Mass spectrometric immunoassay for quantitative determination of transthyretin and its variants.Age-related oxidative modifications of transthyretin modulate its amyloidogenicitySerial scanning with technetium pyrophosphate (99mTc-PYP) in advanced ATTR cardiac amyloidosis.Repression of retinal microvascular endothelial cells by transthyretin under simulated diabetic retinopathy conditions.Transthyretin represses neovascularization in diabetic retinopathy.Pre-plaque conformational changes in Alzheimer's disease-linked Aβ and APP.Amyloid-clearing proteins and their epigenetic regulation as a therapeutic target in Alzheimer's disease.Increased expression of transthyretin in leptin-deficient ob/ob mice is not causative for their major phenotypic abnormalities.The bovine milk proteome: cherishing, nourishing and fostering molecular complexity. An interactomics and functional overview.Causally treatable, hereditary neuropathies in Fabry's disease, transthyretin-related familial amyloidosis, and Pompe's disease.Diagnostic performance of a seven-marker serum protein biosignature for the diagnosis of active TB disease in African primary healthcare clinic attendees with signs and symptoms suggestive of TB.Transthyretin proteins regulate angiogenesis by conferring different molecular identities to endothelial cellsLow prealbumin is a significant predictor of medical complications in severe anorexia nervosa.Aged vervet monkeys developing transthyretin amyloidosis with the human disease-causing Ile122 allele: a valid pathological model of the human disease.Pathogenic Mutations Induce Partial Structural Changes in the Native β-Sheet Structure of Transthyretin and Accelerate Aggregation.Suppressing transthyretin production in mice, monkeys and humans using 2nd-Generation antisense oligonucleotides.Negative effects of transthyretin in high myopic vitreous on diabetic retinopathy.
P2860
Q21202832-E5D0E95E-9ACC-4973-9C2E-249A6767A335Q26764754-7366F50D-7DC2-4DB5-8AA3-F37098D9FC4CQ26771533-761D22BE-01D3-4332-B373-0876755733FAQ26786816-1FEA0C76-30BF-4502-8F44-D5AAF54B8326Q28476502-92C15D35-F71E-4CFE-A099-41BA66CDFFDFQ28743561-E74F90A0-66D6-4C4D-AB07-33206E495E15Q30244227-BFBA875B-6139-43CA-9DC6-5E5AD0DC2A46Q33676625-025DBF63-9F02-4266-A2DA-AB1D4A9CA584Q33692420-CE57A178-E595-4A66-89B0-F8E5C10E5B42Q33932016-56A4DA6C-57C7-41C4-A776-EFEAAC8A3C10Q34073701-7D30D37F-06FA-4F09-8A5A-1DE177438010Q34180244-EF6AD954-8680-4289-8B60-BBF6199B9C87Q34282469-DDA1AE8E-7B4A-4968-9BB1-B1C531FA86ADQ34379670-7EAFF0C5-98A4-4C83-97E8-2FC5D386D4B1Q34561167-93BC985F-264C-4A8E-AB08-06EC50BBD222Q34805156-381B57F0-5757-4335-BE1B-19CBF92A5408Q34951860-093F34FA-0276-4DE8-815B-EDB948A36E4DQ35001154-5E673CC2-3D8D-46DA-9F18-463FF3BAF19BQ35082885-BA1186F0-7E50-4A91-92F8-72724A1608FDQ35133371-9CEAF422-0B99-4598-AB63-B01B92C90C7BQ35212537-B2D8F748-503C-4556-A815-2474F9DD2202Q35448094-D0ADC216-42C6-4945-B69B-52E2D2DC7A45Q35478457-EA7D7873-9EA0-4A7A-A49A-9665BD4C1E82Q36142761-363A4DC9-4863-4C34-9477-589437BC71FCQ36704037-5FC96479-5876-42B5-9A07-DB0988443C25Q36783800-F56AE7CB-92D2-4B5F-B959-355D47C7D773Q37026770-3E0709E5-3B8D-4CF2-993C-54DF695C339AQ37337158-E1D071F5-A5E6-4027-AC59-87013BCF0AA7Q37707805-B9032963-AD41-42F4-BD27-3AFB33E574C5Q38256360-192DFF63-189B-46CA-808C-46A3B8871477Q38323032-D16A8E0D-A643-432C-96B8-7FE28B05D87FQ38504850-D482DDC8-4B1B-463E-8715-952AAE75959AQ38745211-DBF5F110-1F14-42D0-91EA-9923F0F621F3Q38854712-1AC155EB-035F-4970-AC5F-777367F48F18Q42275424-110736C5-5131-4258-8525-FC48BB546435Q43455396-C675EBB3-6FA0-467A-BD9D-2AD02073F84AQ45899656-F1B82DF0-E53C-4245-A393-F76F8A220EEAQ46171494-D5104614-C48F-4410-B3CC-9A19829A6D60Q46476158-9474924A-1AAD-47BF-81A2-CE59A626708CQ47104291-A374149B-B347-43A1-B166-CAFCA60BC3E6
P2860
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
2009年论文
@zh
2009年论文
@zh-cn
name
Transthyretin: the servant of many masters.
@ast
Transthyretin: the servant of many masters.
@en
type
label
Transthyretin: the servant of many masters.
@ast
Transthyretin: the servant of many masters.
@en
prefLabel
Transthyretin: the servant of many masters.
@ast
Transthyretin: the servant of many masters.
@en
P2860
P1476
Transthyretin: the servant of many masters
@en
P2860
P2888
P304
P356
10.1007/S00018-009-0109-0
P577
2009-07-31T00:00:00Z